The combination of CCBs and RAAS inhibitors, including angiotensin converting enzyme inhibitor (ACEI) and AT1 receptor blockers (ARBs), is a common anti-hypertension therapy. This evidence concerns the gene AGTR1 and hypertensive disorder.